Technology | Hemodynamic Support Devices

June 12, 2017 — TandemLife began its commercial launch of the TandemLife Priming Tray, a new product designed to ...

Home June 12, 2017
Home
News | Stem Cell Therapies

June 12, 2017 — Heart muscle is one of the least renewable tissues in the body, which is one of the reasons that heart ...

Home June 12, 2017
Home
News | Cardiovascular Ultrasound

June 12, 2017 — A study using strain imaging presented at the American Society of Echocardiography (ASE) 2017 ...

Home June 12, 2017
Home
News

June 12, 2017 – The Medtronic Resolute Onyx Drug-Eluting Stent (DES) met its primary endpoint of target lesion failure ...

Home June 12, 2017
Home
FDA clears Claret Medical Sentinel embolic protection device for TAVR
Feature | Heart Valve Technology

June 5, 2017 – The U.S. Food and Drug Administration (FDA) granted market clearance for the Claret Medical Sentinel ...

Home June 09, 2017
Home
Videos | Cardiovascular Ultrasound

Chi-Ming Chow, M.D., MSc, FRCPC, FACC, FASE, attending staff cardiologist, St. Michael's Hospital, and associate professor, Department of Medicine, University of Toronto, discusses new technology trends in ultrasound and what developments will effect the future of cardiac ultrasound.

Home June 07, 2017
Home
Videos | Cardiovascular Business

Andrea Natale, M.D., FACC, FHRS, FESC, executive medical director, Texas Cardiac Arrhythmia Institute at St. David's ...

Home June 06, 2017
Home
Sapien 3 valve for VIV (valve in valve) procedures cleared by FDA
Feature | Heart Valve Technology | Dave Fornell

The U.S. Food and Drug Administration (FDA) has granted market clearance for aortic and mitral valve-in-valve procedures using the Edwards Lifesciences Sapien 3 transcatheter heart valve (THV). The Sapien 3 valve is the first transcatheter heart valve approved in the U.S. for the treatment of both aortic and mitral patients who are at high risk for a subsequent open-heart surgery to replace their bioprosthetic valve.

Home June 06, 2017
Home
News | Cardiovascular Ultrasound

June 1, 2017 — More than 50 companies and organizations will display their latest products and services at the American ...

Home June 01, 2017
Home
Biosense Webster's multi-electrode RF ablation balloon
Feature | Dave Fornell

June 1, 2017 — Here is the list of the most popular pieces of content on the Diagnostic and Interventional Cardiology ...

Home June 01, 2017
Home
News | Wearables

Northwell Health recently announced a new partnership agreement with Peerbridge Health Inc., to explore the future of remote medical monitoring. Peerbridge technology enables remote patient monitoring through multiple on-body wireless sensors.

Home June 01, 2017
Home
Technology | Radiation Dose Management

June 1, 2017 — Infab Corp. recently introduced Revolution Lead and Lead-Free Aprons with Kiarmor, Infab’s proprietary bi ...

Home June 01, 2017
Home
Videos | Implantable Cardioverter Defibrillator (ICD)

Lucas Boersma, M.D., Ph.D., FESC, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands, discusses how subcutaneous ...

Home June 01, 2017
Home
Trends and videos for new cardiac ultrasound echocardiography technology advances at ASE
Feature | ASE

ASE Announces Meeting Highlights for 28th Annual Scientific Sessions — The program includes learning opportunities from ...

Home June 01, 2017
Home
News | Heart Valve Technology

LivaNova PLC recently announced the presentation of data from multiple studies demonstrating the safety and effectiveness of the PercevalM sutureless valve for aortic valve replacement (AVR) patients and the Memo 3D ReChord for mitral valve repair. The three data presentations on Perceval, which included a late-breaking clinical trial and a poster presentation on the Memo 3D ReChord, were unveiled at the American Association for Thoracic Surgery (AATS) Centennial meeting in Boston, April 29 – May 3.

Home May 31, 2017
Home
Subscribe Now